Breast  ||| S:0 E:7 ||| JJ
cancer  ||| S:7 E:14 ||| NN
trends  ||| S:14 E:21 ||| NNS
in  ||| S:21 E:24 ||| IN
Latin  ||| S:24 E:30 ||| NNP
America  ||| S:30 E:38 ||| NNP
and  ||| S:38 E:42 ||| CC
the  ||| S:42 E:46 ||| DT
Caribbean  ||| S:46 E:56 ||| NNP
Breast  ||| S:56 E:63 ||| NNP
cancer  ||| S:63 E:70 ||| NN
is  ||| S:70 E:73 ||| VBZ
currently  ||| S:73 E:83 ||| RB
the  ||| S:83 E:87 ||| DT
most  ||| S:87 E:92 ||| RBS
significant  ||| S:92 E:104 ||| JJ
cause  ||| S:104 E:110 ||| NN
of  ||| S:110 E:113 ||| IN
death  ||| S:113 E:119 ||| NN
from  ||| S:119 E:124 ||| IN
malignancies  ||| S:124 E:137 ||| NN
in  ||| S:137 E:140 ||| IN
Latin  ||| S:140 E:146 ||| NNP
American  ||| S:146 E:155 ||| NNP
women ||| S:155 E:160 ||| NNS
,  ||| S:160 E:162 ||| ,
including  ||| S:162 E:172 ||| VBG
cervical  ||| S:172 E:181 ||| JJ
cancer ||| S:181 E:187 ||| NN
.  ||| S:187 E:189 ||| .
Describe  ||| S:189 E:198 ||| VB
the  ||| S:198 E:202 ||| DT
magnitude  ||| S:202 E:212 ||| NN
and  ||| S:212 E:216 ||| CC
spatial-temporal  ||| S:216 E:233 ||| JJ
distribution  ||| S:233 E:246 ||| NN
of  ||| S:246 E:249 ||| IN
breast  ||| S:249 E:256 ||| JJ
cancer  ||| S:256 E:263 ||| NN
in  ||| S:263 E:266 ||| IN
Latin  ||| S:266 E:272 ||| NNP
America  ||| S:272 E:280 ||| NNP
and  ||| S:280 E:284 ||| CC
the  ||| S:284 E:288 ||| DT
Caribbean  ||| S:288 E:298 ||| NNP
( ||| S:298 E:299 ||| -LRB-
LAC ||| S:299 E:302 ||| NNP
)  ||| S:302 E:304 ||| -RRB-
from  ||| S:304 E:309 ||| IN
1979-2005 ||| S:309 E:318 ||| CD
.  ||| S:318 E:320 ||| .
National  ||| S:320 E:329 ||| NNP
and  ||| S:329 E:333 ||| CC
international  ||| S:333 E:347 ||| JJ
incidence  ||| S:347 E:357 ||| NN
and  ||| S:357 E:361 ||| CC
mortality  ||| S:361 E:371 ||| NN
statistics  ||| S:371 E:382 ||| NNS
were  ||| S:382 E:387 ||| VBD
reviewed  ||| S:387 E:396 ||| VBN
and  ||| S:396 E:400 ||| CC
organized  ||| S:400 E:410 ||| JJ
( ||| S:410 E:411 ||| -LRB-
registries ||| S:411 E:421 ||| UH
,  ||| S:421 E:423 ||| ,
databases ||| S:423 E:432 ||| NN
,  ||| S:432 E:434 ||| ,
and  ||| S:434 E:438 ||| CC
published  ||| S:438 E:448 ||| VBN
literature ||| S:448 E:458 ||| NN
) ||| S:458 E:459 ||| -RRB-
,  ||| S:459 E:461 ||| ,
basic  ||| S:461 E:467 ||| JJ
estimators  ||| S:467 E:478 ||| NNS
and  ||| S:478 E:482 ||| CC
mortality  ||| S:482 E:492 ||| NN
ratios  ||| S:492 E:499 ||| NNS
for  ||| S:499 E:503 ||| IN
each  ||| S:503 E:508 ||| DT
country  ||| S:508 E:516 ||| NN
were  ||| S:516 E:521 ||| VBD
calculated  ||| S:521 E:532 ||| VBN
and  ||| S:532 E:536 ||| CC
trends  ||| S:536 E:543 ||| NNS
were  ||| S:543 E:548 ||| VBD
analyzed ||| S:548 E:556 ||| VBN
.  ||| S:556 E:558 ||| .
Despite  ||| S:558 E:566 ||| IN
substantial  ||| S:566 E:578 ||| JJ
data  ||| S:578 E:583 ||| NNS
gaps  ||| S:583 E:588 ||| VBN
in  ||| S:588 E:591 ||| IN
incidence  ||| S:591 E:601 ||| NN
for  ||| S:601 E:605 ||| IN
many  ||| S:605 E:610 ||| JJ
countries ||| S:610 E:619 ||| NNS
,  ||| S:619 E:621 ||| ,
an  ||| S:621 E:624 ||| DT
increase  ||| S:624 E:633 ||| NN
in  ||| S:633 E:636 ||| IN
incidence  ||| S:636 E:646 ||| NN
and  ||| S:646 E:650 ||| CC
mortality  ||| S:650 E:660 ||| NN
is  ||| S:660 E:663 ||| VBZ
observed  ||| S:663 E:672 ||| VBN
in  ||| S:672 E:675 ||| IN
LAC  ||| S:675 E:679 ||| NNP
countries ||| S:679 E:688 ||| NNS
.  ||| S:688 E:690 ||| .
Deaths ||| S:690 E:696 ||| NNP
/ ||| S:696 E:697 ||| NNP
cases  ||| S:697 E:703 ||| NNS
ratios  ||| S:703 E:710 ||| NNS
illustrate  ||| S:710 E:721 ||| VBP
problems  ||| S:721 E:730 ||| NNS
in  ||| S:730 E:733 ||| IN
access  ||| S:733 E:740 ||| NN
to  ||| S:740 E:743 ||| TO
detection  ||| S:743 E:753 ||| VB
and  ||| S:753 E:757 ||| CC
treatment  ||| S:757 E:767 ||| NN
and  ||| S:767 E:771 ||| CC
the  ||| S:771 E:775 ||| DT
greatest  ||| S:775 E:784 ||| JJS
gaps  ||| S:784 E:789 ||| NNS
are  ||| S:789 E:793 ||| VBP
observed  ||| S:793 E:802 ||| VBN
in  ||| S:802 E:805 ||| IN
poorer  ||| S:805 E:812 ||| JJR
countries ||| S:812 E:821 ||| NNS
.  ||| S:821 E:823 ||| .
A  ||| S:823 E:825 ||| DT
regional  ||| S:825 E:834 ||| JJ
effort  ||| S:834 E:841 ||| NN
is  ||| S:841 E:844 ||| VBZ
needed  ||| S:844 E:851 ||| VBN
to  ||| S:851 E:854 ||| TO
improve  ||| S:854 E:862 ||| VB
information  ||| S:862 E:874 ||| NN
systems  ||| S:874 E:882 ||| NNS
related  ||| S:882 E:890 ||| VBN
to  ||| S:890 E:893 ||| TO
cancer  ||| S:893 E:900 ||| NN
in  ||| S:900 E:903 ||| IN
general  ||| S:903 E:911 ||| JJ
and  ||| S:911 E:915 ||| CC
breast  ||| S:915 E:922 ||| JJ
cancer  ||| S:922 E:929 ||| NN
in  ||| S:929 E:932 ||| IN
particular ||| S:932 E:942 ||| JJ
.  ||| S:942 E:944 ||| .
It  ||| S:944 E:947 ||| PRP
is  ||| S:947 E:950 ||| VBZ
imperative  ||| S:950 E:961 ||| VBN
to  ||| S:961 E:964 ||| TO
develop  ||| S:964 E:972 ||| VB
strategies  ||| S:972 E:983 ||| NNS
to  ||| S:983 E:986 ||| TO
improve  ||| S:986 E:994 ||| VB
diagnostic  ||| S:994 E:1005 ||| JJ
infrastructure  ||| S:1005 E:1020 ||| NN
in  ||| S:1020 E:1023 ||| IN
order  ||| S:1023 E:1029 ||| NN
to  ||| S:1029 E:1032 ||| TO
achieve  ||| S:1032 E:1040 ||| VB
early  ||| S:1040 E:1046 ||| JJ
detection  ||| S:1046 E:1056 ||| NN
and  ||| S:1056 E:1060 ||| CC
effective  ||| S:1060 E:1070 ||| JJ
treatment  ||| S:1070 E:1080 ||| NN
and  ||| S:1080 E:1084 ||| CC
halt  ||| S:1084 E:1089 ||| VB
the  ||| S:1089 E:1093 ||| DT
upward  ||| S:1093 E:1100 ||| JJ
trend  ||| S:1100 E:1106 ||| NN
in  ||| S:1106 E:1109 ||| IN
premature  ||| S:1109 E:1119 ||| JJ
mortality ||| S:1119 E:1128 ||| NN
.  ||| S:1128 E:1130 ||| .
